Close Menu

NEW YORK (GenomeWeb) – Australia's Sonic Healthcare said today it has signed an agreement to offer Contextual Genomics' Find-It solid tumor test through its international network of laboratories.

Find-It is a next-generation sequencing-based multiplex assay that screens for 90 mutations across 29 known cancer genes and analyzes eight exons of three genes to help clinicians select the best treatment for a specific patient, recognize acquired drug-resistant mutations, and determine prognostic and diagnostic implications for patient care.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
13

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Jun
17

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.